National Health Cost & Accountability Act of 2025 (NHCAA)
National Health Cost & Accountability Act of 2025 (NHCAA)
Umbrella healthcare reform bill built from prior
enacted-draft texts and standards; structured in HOLC style for congressional
submission.
✅ Plain‑English Summary
(Checkmarks)
- ✅
It’s a price‑gouging crisis, not a care crisis. Caps prices to OECD‑benchmarks
and outlaws junk “facility fees.”
- ✅
Essential medicines become affordable by design. Insulin and life‑saving
drugs get strict price controls, transparency, and nonprofit manufacturing
backstops.
- ✅
Real transparency with teeth. Mandatory up‑front pricing for
hospitals, clinics, labs, imaging; daily fines for non‑compliance.
- ✅
Youth protection. Restricts high‑caffeine marketing/sales to
minors; bans caffeinated drinks in K–12.
- ✅
Workplace health is healthcare. OSHA‑aligned indoor‑air, chemical,
and ergonomic standards tied to payer participation.
- ✅
Pets are family. National pet healthcare framework (subsidies +
pricing standards) to end euthanasia by cost.
- ✅
Nonprofit-first model. Incentivizes hospital nonprofit conversion
and ties executive compensation to median staff pay.
Table of Contents
- Title
I — Findings; Purpose; Definitions
- Title
II — National Price Standards & Anti‑Gouging
- Title
III — Hospital & Insurer Transparency
- Title
IV — Essential Medicines & Insulin Affordability
- Title
V — Youth Health & Caffeine Controls
- Title
VI — Workplace Health Standards (Healthcare Linkage)
- Title
VII — Veterinary & Public Health Integration
- Title
VIII — Oversight, Enforcement, and Penalties
- Title
IX — Funding; Implementation; Reports
- Title
X — General Provisions (Severability; Effective Date)
Title I — Findings; Purpose; Definitions
Sec. 101. Findings
- The
United States pays the highest healthcare prices among peer nations,
absent effective national price regulation.
- Price
opacity and market consolidation permit extraction of economic rents, not
correlated with outcomes.
- Essential
medicines (including insulin) and emergency therapeutics must be
accessible at predictable, regulated prices.
- Youth
exposure to high‑caffeine beverages correlates with adverse physical and
mental outcomes; schools require protective standards.
- Workplace
health (air quality, chemical exposure, ergonomics) directly drives
morbidity and payer costs; federal standards must be harmonized and
enforced.
- Companion‑animal
healthcare costs create household distress and public‑health
externalities; basic veterinary access is in the national interest.
Sec. 102. Purpose
To treat healthcare as a regulated public utility with (1)
national price standards, (2) universal transparency, (3) essential‑medicine
affordability, (4) youth protections, (5) integrated workplace‑health
enforcement, and (6) companion‑animal care access.
Sec. 103. Definitions
Key terms shall include: "essential medicine,"
"benchmark price," "facility fee," "payer,"
"provider," "youth/high‑caffeine beverage," "covered
veterinary service," and others as defined by the Secretary in rulemaking.
Title II — National Price Standards & Anti‑Gouging
Sec. 201. Benchmark Price Caps
(a) The Secretary shall set national benchmark prices for ER
visits, imaging, labs, inpatient DRGs, and common outpatient procedures at ≤150%
of OECD median for equivalent services.
(b) Annual adjustments follow CPI‑U or 2%, whichever is lower, unless evidence
shows a quality‑of‑care compromise.
Sec. 202. Facility Fee Reform
(a) Prohibits non‑hospital outpatient "facility
fees" unless clinically required and pre‑disclosed; violations result in
per‑claim civil penalties.
Sec. 203. Anti‑Consolidation & Ownership Conflicts
(a) Bars common ownership/control between hospitals,
insurers, and PBMs beyond de‑minimis thresholds; requires divestiture plans.
Title III — Hospital & Insurer Transparency
Sec. 301. Real‑Time Price Disclosure
(a) Providers must publish consumer‑facing prices (bundled
and itemized) for all shoppable services.
(b) Non‑compliance: daily fines scaled by system revenue; repeat violations
trigger Medicare/Medicaid participation holds.
Sec. 302. Advance Cost Estimates
(a) Mandates written good‑faith estimates before non‑emergent
care; bans surprise billing across all provider types.
Title IV — Essential Medicines & Insulin
Affordability
Sec. 401. Insulin Affordability & Access
(a) Insulin subject to national ceiling price; mandatory
coverage at $0 copay for chronic users; distribution safeguards for purity and
authenticity.
(b) Corporate transparency on cost of goods (COGS), R&D tax credits, and
transfer pricing; penalties for misreporting.
Sec. 402. Essential Medicines Program
(a) Establishes a federal nonprofit generics manufacturer to
supply designated essential medicines during price spikes or shortages.
(b) Caps annual list‑price increases at CPI‑U (or 2%).
Sec. 403. Corporate Incentives & Oversight
(a) Temporary tax credits for voluntary price reductions
meeting federal targets; clawbacks for non‑compliance.
(b) Annual public reporting; independent audit authority.
Title V — Youth Health & Caffeine Controls
Sec. 501. Labeling & Marketing Restrictions
(a) Prominent caffeine warnings; bans targeted marketing of
high‑caffeine beverages to individuals under 16.
Sec. 502. Age‑Restricted Sales & School Protections
(a) Prohibits sale of high‑caffeine beverages to persons
under 16.
(b) Bans caffeinated beverages in K–12 campuses, with enforcement by state
education agencies.
Title VI — Workplace Health Standards (Healthcare
Linkage)
Sec. 601. OSHA‑Linked Health Compliance
(a) Aligns payer participation with demonstrable compliance
on indoor air quality (IAQ), chemical exposure controls (e.g., fume hoods), and
ergonomics.
(b) Requires annual IAQ testing and HVAC maintenance; establishes whistleblower
safe‑harbors; ties repeated violations to federal contracting eligibility.
Title VII — Veterinary & Public Health Integration
Sec. 701. Federal Veterinary Care Subsidy Program (FVCS)
(a) Sliding‑scale subsidies up to 80% for eligible
households (≤300% FPL) covering routine, emergency, diagnostics, meds.
Sec. 702. Federal Pet Health Insurance Program (FPHIP)
(a) Affordable national plans with chronic‑care coverage and
minimized cost‑sharing for low‑income households.
Sec. 703. Veterinary Pricing Standards & Transparency
(a) Standardized pricing schedules for common procedures;
mandatory up‑front quotes.
Sec. 704. Vector‑Borne Disease Control & Research
(a) Authorizes R&D on sustainable vector control
(including targeted irradiation and immunity‑based approaches) with
environmental safeguards.
Title VIII — Oversight, Enforcement, and Penalties
Sec. 801. Independent Health Pricing Commission
(a) Sets/updates benchmarks; investigates gouging;
recommends civil/criminal referrals.
Sec. 802. Data, Audits, and Whistleblowers
(a) Robust data‑submission authority; audit rights; anti‑retaliation
protections with statutory damages.
Sec. 803. Penalties
(a) Scaled civil penalties for price and transparency
violations; treble damages for willful fraud; exclusion authority for repeat
offenders.
Title IX — Funding; Implementation; Reports
Sec. 901. Appropriations
(a) Such sums as necessary; CBO‑scorable offsets via waste‑reduction
and anti‑gouging recoveries.
Sec. 902. Implementation Timeline
(a) 12 months for rulemaking; staged go‑live for Titles
II–VII.
Sec. 903. Reports to Congress
(a) Annual public reports on price trends, access, outcomes,
and enforcement actions.
Title X — General Provisions
Sec. 1001. Severability
If any provision is held invalid, the remainder remains in
effect.
Sec. 1002. Effective Date
This Act takes effect 90 days after enactment unless
otherwise specified.
Notes for Drafting Team (Internal)
- Conform
terminology and numbering to House Office of Legislative Counsel (HOLC)
style.
- Attach
regulatory cross‑walks to existing CFR titles (OSHA, HHS/CMS, FDA) in the
drafting memo.
- Prepare
one‑page Hill summary, press sheet, and citizen explainer.
- Build
annexes: (A) OECD price tables; (B) Essential‑medicine list; (C)
IAQ/chemical standards; (D) Youth caffeine evidence brief; (E) Veterinary
pricing model.
Comments
Post a Comment